Skúšobnú verziu novej webovej stránky nájdete na beta.sukl.sk. Všetky aktuality, informácie a kompletný obsah sú zatiaľ prioritne dostupné na pôvodnej verzii webu.
en

PRODUCT DETAIL

Androject 1 000 mg/4 ml injekčný roztok

Code 2105F
MA number 56/0415/25-S
Product Form: sol inj 1x4 ml/1 000 mg (liek.inj.skl.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Mutual recognition procedure
MAH, country: Besins Healthcare Ireland Limited, Ireland
Therapeutic Class: 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)
ATC:
G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G03B ANDROGENS
G03BA 3-oxoandrosten (4) derivatives
G03BA03 Testosterone
Shelf life: 36
Container: glass vial
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 03.01.2026
Validity: 03.01.2031
Pediatric warnings: Yes
SPC: SPC_Androject 1 000 mg_4 ml sol inj_12_2025.pdf  
PIL: PIL_Androject 1 000 mg_4 ml sol inj_12_2025.pdf  
Safety feature Yes
Data update: 23.02.2026
eu-flag.png sk-flag.png